1-1 of 1
Akihito Momoi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Jun Takizawa, MD, PhD, Sadao Aoki, MD, PhD, Kazue Takai, MD, Tohri Kurasaki, MD, Keiichiro Honma, MD, Masutaka Higashimura, MD, Kouichi Nagai, MD, Akihito Momoi, MD, PhD, Koji Nikkuni, MD, PhD, Yoshufusa Aizawa, MD
Journal: Blood
Blood (2005) 106 (11): 4734.
https://doi.org/10.1182/blood.V106.11.4734.4734
Published: 2005